Antibe Therapeutics Inc. (TSE:ATE – Get Free Report)’s share price traded up 13.5% on Monday . The company traded as high as C$0.35 and last traded at C$0.30. 167,044 shares changed hands during mid-day trading, an increase of 23% from the average session volume of 135,475 shares. The stock had previously closed at C$0.26.
Antibe Therapeutics Trading Up 13.5 %
The company has a quick ratio of 9.58, a current ratio of 10.06 and a debt-to-equity ratio of 0.29. The stock’s fifty day simple moving average is C$0.30. The company has a market capitalization of C$15.64 million, a PE ratio of -0.84 and a beta of 0.19.
Antibe Therapeutics Company Profile
Antibe Therapeutics Inc, a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's pipeline includes therapies that seek to overcome the gastrointestinal (GI) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs).
See Also
- Five stocks we like better than Antibe Therapeutics
- What is the Shanghai Stock Exchange Composite Index?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- How to buy stock: A step-by-step guide for beginners
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- The 3 Best Retail Stocks to Shop for in August
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Antibe Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Antibe Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
